In human hepatoma cells, suppression of MAOB activity significantly decreased endogenous levels of geranylgeranoic acid (GGA), an agent that prevents secondary primary hepatoma through oxidation of geranylgeraniol [51]. Here, MAOB is linked to hepatocellular carcinoma.